Covenant Health Fort Sanders Regional First in Tennessee to Bring Perimeter Medical Imaging AI's Pioneering Technology to Surgery
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF) announced that Covenant Health Fort Sanders Regional has become the first hospital in Tennessee to implement their S-Series OCT (Optical Coherence Tomography) technology for visualizing tissue margins during surgery.
The S-Series OCT technology provides real-time margin visualization with resolution 10 times higher than ultrasound and X-ray, and 100 times more powerful than MRI. It can visualize tissue microstructures down to 2mm in ducts, vessels, and glands, potentially reducing the need for follow-up surgeries by eliminating the traditional 10-day wait for pathology results.
Dr. Ana Wilson, a surgical oncologist at Covenant Health Fort Sanders Regional, highlighted how the technology enables patient-specific surgical decisions in real-time. The implementation represents a significant milestone in Perimeter's nationwide expansion strategy and aligns with their goal of improving surgical outcomes while reducing healthcare costs.
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF) ha annunciato che il Covenant Health Fort Sanders Regional è diventato il primo ospedale nel Tennessee ad implementare la loro tecnologia S-Series OCT (Tomografia a Coerenza Ottica) per visualizzare i margini dei tessuti durante l'intervento chirurgico.
La tecnologia S-Series OCT offre visualizzazione dei margini in tempo reale con una risoluzione 10 volte superiore a quella dell'ultrasuono e delle radiografie, e 100 volte più potente rispetto alla risonanza magnetica. È in grado di visualizzare le microstrutture tissutali fino a 2mm in dotti, vasi e ghiandole, potenzialmente riducendo la necessità di interventi chirurgici di follow-up eliminando l'attesa tradizionale di 10 giorni per i risultati della patologia.
La Dr.ssa Ana Wilson, oncologa chirurgica presso il Covenant Health Fort Sanders Regional, ha sottolineato come la tecnologia consenta decisioni chirurgiche specifiche per il paziente in tempo reale. L'implementazione rappresenta un traguardo significativo nella strategia di espansione nazionale di Perimeter e si allinea con il loro obiettivo di migliorare i risultati chirurgici riducendo al contempo i costi sanitari.
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF) anunció que Covenant Health Fort Sanders Regional se ha convertido en el primer hospital en Tennessee en implementar su tecnología S-Series OCT (Tomografía de Coherencia Óptica) para visualizar los márgenes de los tejidos durante la cirugía.
La tecnología S-Series OCT proporciona visualización de márgenes en tiempo real con una resolución 10 veces mayor que la del ultrasonido y la radiografía, y 100 veces más potente que la resonancia magnética. Puede visualizar microestructuras de tejido hasta 2 mm en conductos, vasos y glándulas, potencialmente reduciendo la necesidad de cirugías de seguimiento al eliminar la espera tradicional de 10 días para los resultados de patología.
La Dra. Ana Wilson, oncóloga quirúrgica en Covenant Health Fort Sanders Regional, destacó cómo la tecnología permite decisiones quirúrgicas específicas para el paciente en tiempo real. La implementación representa un hito significativo en la estrategia de expansión nacional de Perimeter y se alinea con su objetivo de mejorar los resultados quirúrgicos mientras se reducen los costos de atención médica.
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF)는 Covenant Health Fort Sanders Regional이 테네시주에서 수술 중 조직 경계를 시각화하기 위해 S-Series OCT(광학 단층 촬영) 기술을 최초로 도입했다고 발표했습니다.
S-Series OCT 기술은 실시간 경계 시각화를 제공하며, 초음파 및 X선보다 10배 높은 해상도와 MRI보다 100배 더 강력합니다. 이 기술은 관, 혈관 및 샘에서 2mm까지의 조직 미세 구조를 시각화할 수 있어, 병리학 결과를 기다리는 전통적인 10일 대기 시간을 없애고 후속 수술의 필요성을 줄일 수 있습니다.
Covenant Health Fort Sanders Regional의 외과 종양학자인 Ana Wilson 박사는 이 기술이 환자 맞춤형 수술 결정을 실시간으로 가능하게 한다고 강조했습니다. 이 도입은 Perimeter의 전국적 확장 전략에서 중요한 이정표를 나타내며, 수술 결과를 개선하고 의료 비용을 줄이는 목표와 일치합니다.
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF) a annoncé que le Covenant Health Fort Sanders Regional est devenu le premier hôpital du Tennessee à mettre en œuvre sa technologie S-Series OCT (Tomographie par Cohérence Optique) pour visualiser les marges tissulaires pendant la chirurgie.
La technologie S-Series OCT fournit une visualisation des marges en temps réel avec une résolution 10 fois supérieure à celle de l'échographie et des rayons X, et 100 fois plus puissante que l'IRM. Elle peut visualiser les microstructures tissulaires jusqu'à 2 mm dans les canaux, les vaisseaux et les glandes, réduisant potentiellement le besoin de chirurgies de suivi en éliminant l'attente traditionnelle de 10 jours pour les résultats pathologiques.
Le Dr Ana Wilson, oncologue chirurgicale au Covenant Health Fort Sanders Regional, a souligné comment la technologie permet des décisions chirurgicales spécifiques au patient en temps réel. Cette mise en œuvre représente une étape importante dans la stratégie d'expansion nationale de Perimeter et s'aligne avec leur objectif d'améliorer les résultats chirurgicaux tout en réduisant les coûts de santé.
Perimeter Medical Imaging AI (TSXV: PINK, OTCQX: PYNKF) gab bekannt, dass das Covenant Health Fort Sanders Regional das erste Krankenhaus in Tennessee ist, das die S-Series OCT (Optische Kohärenztomographie) Technologie zur Visualisierung von Gewebemargen während der Chirurgie implementiert hat.
Die S-Series OCT Technologie bietet echtzeitige Margenvisualisierung mit einer 10-fach höheren Auflösung als Ultraschall und Röntgen sowie 100-fach leistungsstärker als die MRT. Sie kann Gewebemikrostrukturen bis zu 2 mm in Gängen, Gefäßen und Drüsen visualisieren und potenziell die Notwendigkeit von Nachoperationen reduzieren, indem sie die traditionelle 10-tägige Wartezeit auf pathologische Ergebnisse eliminiert.
Dr. Ana Wilson, eine chirurgische Onkologin am Covenant Health Fort Sanders Regional, hob hervor, wie die Technologie patientenspezifische chirurgische Entscheidungen in Echtzeit ermöglicht. Die Implementierung stellt einen bedeutenden Meilenstein in Perimeters nationaler Expansionsstrategie dar und steht im Einklang mit ihrem Ziel, die chirurgischen Ergebnisse zu verbessern und gleichzeitig die Gesundheitskosten zu senken.
- First-to-market achievement in Tennessee, expanding geographic presence
- Technology offers superior resolution compared to traditional imaging methods
- Potential to reduce follow-up surgeries and healthcare costs
- Real-time decision making capability during surgery
- None.
"OCT technology enhances the level of care I am able to provide and has become a valuable tool in the operating room," said Dr. Ana Wilson, a surgical oncologist with Covenant Health Fort Sanders Regional. "It allows me to make patient-specific surgical decisions in real-time and potentially reduce the likelihood of my patients returning for a second surgery."
Traditional technologies such as X-ray, ultrasound or MRI don't have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either confirm clean margins or show positive margins, which often result in patients returning for another procedure.
"Being the first in
The S-Series OCT uses light to create cross-sectional 3D images of tissue microstructures at 10 times the resolution of ultrasound and X-ray and 100 times the power of magnetic resonance imaging (MRI). With the ability to see down to 2 mm in ducts, vessels and glands in the operating room, surgeons can get real-time clarity on margins, giving them the insight they need to help make the best surgical decisions for their patients and feel more confident in their outcomes.
"Perimeter is working tirelessly to help surgeons provide the best possible care for their patients," said Suzanne Foster, Chairperson of Perimeter's Board of Directors. Suzanne, as a breast cancer survivor, has a personal connection to Perimeter's mission to transform cancer surgery, understanding the need for all patients to have access to advanced technology in hopes to improve surgical outcomes.
About Perimeter Medical Imaging AI, Inc.
Based in
S-Series OCT Intended Use and Unapproved Uses
The S-Series OCT is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization with image review manipulation software for identifying and annotating regions of interest.
The S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established.
For full information on unapproved/off-label uses, visit https://perimetermed.com/disclosures or contact medicalaffairs@perimetermed.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the timing of the annual meeting, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2023, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
Contacts
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com
Susan Thomas
Media Relations
Direct: 619-540-9195
Email: susan@endpointcommunications.net
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/covenant-health-fort-sanders-regional-first-in-tennessee-to-bring-perimeter-medical-imaging-ais-pioneering-technology-to-surgery-302394265.html
SOURCE Perimeter Medical Imaging AI Inc.
FAQ
What advantages does Perimeter's S-Series OCT technology offer over traditional imaging methods for PYNKF?
How does Perimeter's PYNKF S-Series OCT technology impact surgical wait times?
Which hospital first implemented Perimeter's PYNKF S-Series OCT technology in Tennessee?
What are the key benefits of PYNKF's S-Series OCT for surgeons?
